Munro Global Growth Fund (MAET) |
Financials |
$315 |
Monthly Fund Update - April 2025
|
12 May 2025 8:47AM |
$6.620 |
$7.240 |
risen by
9.37%
|
|
TasFoods Limited (TFL) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
2025 AGM CEO Address
|
12 May 2025 8:46AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$52 |
Acceleration of RAD204 Phase 1 dose escalation trial
|
12 May 2025 8:46AM |
$0.022 |
$0.022 |
risen by
2.33%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited accelerates the dose escalation of its RAD204 Phase 1 clinical trial.
- The trial is assessing safety, tolerability, and pharmacokinetics of RAD204 in patients with advanced solid tumors.
- Favorable safety and tolerability data have been observed in early dose cohorts.
- Acceleration allows faster progression through the dose escalation process.
- This move could expedite the clinical development timeline for RAD204.
- Potential for advancement into later stage clinical testing if Phase 1 is successful.
- The announcement highlights RAD's commitment to progressing its radiopharmaceutical pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$31 |
Application for quotation of securities - FBR
|
12 May 2025 8:45AM |
$0.006 |
$0.006 |
fallen by
8.33%
|
|
Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$413 |
Response to ASX Query
|
12 May 2025 8:45AM |
$7.120 |
$5.080 |
fallen by
28.65%
|
|
MYX - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX queried Mayne Pharma regarding recent unusual trading activity.
- Mayne Pharma stated it is not aware of any undisclosed information that could explain the share price movement or increased trading volume.
- The company confirmed it is compliant with ASX Listing Rule 3.1 and its continuous disclosure obligations.
- No recent undisclosed announcements or negotiations are taking place that could be responsible for the trading activity.
- Mayne Pharma described its internal protocols for managing and disclosing market-sensitive information.
- The company reaffirmed its commitment to transparency and governance.
- Mayne Pharma’s Board authorized the response to the ASX query.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
TasFoods Limited (TFL) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
2025 AGM Chairmans Address
|
12 May 2025 8:42AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,461 |
Notification of cessation of securities - MFG
|
12 May 2025 8:42AM |
$8.510 |
$8.490 |
fallen by
0.24%
|
|
Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$8 |
Notification regarding unquoted securities - DAL
|
12 May 2025 8:41AM |
$0.032 |
$0.033 |
risen by
3.13%
|
|
Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,461 |
Update - Notification of buy-back - MFG
|
12 May 2025 8:41AM |
$8.510 |
$8.490 |
fallen by
0.24%
|
|
Top End Energy Limited (TEE) ORDINARY FULLY PAID |
Energy |
$11 |
Key Leasing Milestone Achieved in Kansas
|
12 May 2025 8:41AM |
$0.076 |
$0.041 |
fallen by
46.05%
|
|
TEE - Price-sensitive ASX Announcement
Full Release
Key Points
- Top End Energy Limited (TEE) achieved a key leasing milestone in Kansas.
- TEE has secured leasing agreements over 20,700 net acres.
- The achieved acreage exceeds the minimum threshold required for project advancement.
- The milestone enables TEE to progress with exploration and development activities.
- The Kansas Project targets conventional oil and gas prospects.
- TEE is utilizing local relationships and technical expertise to expand its leasehold.
- The announcement underscores the strategic and value-driven importance of the project.
- TEE plans further expansion and continued growth in Kansas.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$83 |
Update - Notification of buy-back - M7T
|
12 May 2025 8:40AM |
$0.360 |
$0.345 |
fallen by
4.17%
|
|
Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$689 |
Weekly NTA Estimate
|
12 May 2025 8:40AM |
$2.930 |
$3.010 |
risen by
2.73%
|
|
TasFoods Limited (TFL) ORDINARY FULLY PAID |
Consumer Staple |
$2 |
2025 AGM Presentation
|
12 May 2025 8:40AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
TFL - Price-sensitive ASX Announcement
Full Release
Key Points
- 2023 revenue increased compared to previous year but margins were impacted by cost inflation.
- Operational improvements and cost control measures were implemented.
- Significant leadership and board changes occurred.
- Focus on core brands, including dairy (Betta Milk, Pyengana) and poultry (Nichols Poultry).
- Investments made in production facilities to improve capacity and efficiency.
- Governance reforms and improved risk management frameworks introduced.
- Supply chain challenges addressed through new supplier agreements and logistics improvements.
- New product development and product quality initiatives undertaken.
- Brand strategy aimed at premium, sustainable, and local Tasmanian produce.
- Commitment to environmental initiatives, including sustainable packaging and waste reduction.
- Positive outlook for continued growth, improved profitability, and operational stability in 2024 and beyond.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$41 |
Q3 FY2025 business update
|
12 May 2025 8:39AM |
$0.072 |
$0.062 |
fallen by
13.89%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitura Health reported continued revenue and product sales growth in Q3 FY2025.
- The company expanded its medicinal cannabis product portfolio and patient base.
- Vitura achieved regulatory milestones and strengthened strategic partnerships.
- Operational improvements and investments in technology were a focus during the quarter.
- Vitura maintained strong compliance and worked to enhance patient access to medicinal cannabis.
- The company reinforced its leadership in the Australian medicinal cannabis sector.
- Efforts were made to support long-term sustainable growth and explore new market opportunities.
- Increase in both prescribing practitioners and patients was noted.
- Vitura’s strategy includes ongoing infrastructure expansion and innovation.
- The update confirmed ongoing commitment to patient outcomes and regulatory adherence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Althea Group Holdings Limited (AGH) ORDINARY FULLY PAID |
Health Care |
$21 |
Appointment of Chief Financial Officer
|
12 May 2025 8:38AM |
$0.023 |
$0.025 |
risen by
8.70%
|
|
Latitude Group Holdings Limited (LFS) ORDINARY FULLY PAID |
Financials |
$1,170 |
Update - Notification of buy-back - LFSPA
|
12 May 2025 8:38AM |
$1.145 |
$1.125 |
fallen by
1.75%
|
|
DeSoto Resources Limited (DES) ORDINARY FULLY PAID |
Materials |
$24 |
Northern Territory Drilling Commences
|
12 May 2025 8:37AM |
$0.165 |
$0.130 |
fallen by
21.21%
|
|
DES - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling has commenced at the Fenton Gold Project in the Northern Territory.
- Preparatory work included site clearance, access upgrades, and geophysical targeting.
- Initial drilling targets the Fenton Shear Zone and high-priority gold prospects.
- Recent geochemical and geophysical work informed drill targeting.
- Potential for significant gold mineralisation at the project.
- Part of DeSoto’s strategy to become a leading gold explorer in Pine Creek.
- Ongoing community engagement and environmental management are highlighted.
- Focus on unlocking underexplored gold potential in the Pine Creek Orogen.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Tivan Limited (TVN) ORDINARY FULLY PAID |
Materials |
$184 |
Online Investor Briefing Replay
|
12 May 2025 8:33AM |
$0.110 |
$0.089 |
fallen by
19.09%
|
|
Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$303 |
Update - Notification of buy-back - CVW
|
12 May 2025 8:32AM |
$0.460 |
$0.460 |
fallen by
0%
|
|
Minerals 260 Limited (MI6) ORDINARY FULLY PAID |
Materials |
$238 |
Presentation - Investor, Analyst & Media Site Visit
|
12 May 2025 8:32AM |
$0.135 |
$0.115 |
fallen by
14.81%
|
|
Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$2 |
Osteopore partners Kelyniam for US craniofacial business
|
12 May 2025 8:30AM |
$0.014 |
$0.010 |
fallen by
28.57%
|
|
Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$4,938 |
2025 Half Year Results Investor Presentation
|
12 May 2025 8:30AM |
$2.570 |
$2.680 |
risen by
4.28%
|
|
DNL - Price-sensitive ASX Announcement
Full Release
Key Points
- DNL reported solid financial performance for the first half of 2025.
- Strong operational results were achieved across both Asia Pacific and Americas regions.
- Strategic investments continue in technology, sustainability, and customer-focused solutions.
- The presentation highlights a commitment to safety and sustainable business practices.
- Market conditions remain dynamic, with continued focus on cost discipline and operational efficiency.
- DNL is investing in innovation to drive future growth and enhance competitiveness.
- Capital management initiatives support shareholder value and company resilience.
- Guidance for the remainder of the fiscal year is provided, outlining expected opportunities and challenges.
- The company remains focused on disciplined execution of its growth strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$4,618 |
Update - Notification of buy-back - WHC
|
12 May 2025 8:30AM |
$5.160 |
$5.520 |
risen by
6.98%
|
|
Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$212 |
Application for quotation of securities - RXL
|
12 May 2025 8:30AM |
$0.315 |
$0.290 |
fallen by
7.94%
|
|
VHM Limited (VHM) ORDINARY FULLY PAID |
Materials |
$53 |
Proposed issue of securities - VHM
|
12 May 2025 8:30AM |
$0.325 |
$0.210 |
fallen by
35.38%
|
|